TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ID SOLUTIONS ONCOLOGY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

ID SOLUTIONS ONCOLOGY

ST13

US500000079410002

Class

1, 5, 9, 10, 42

Filing

79410002

Registration

8105620

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

07/16/2026

Classification

Registered

Trademark type

Combined

Nice classes

1, 5, 9, 10, 42

Filing date

09/03/2024

Registration date

01/20/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/20/2026

Last transaction

07/16/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

34

Owner location

FR

Examiner

THOMAS, JULIE

Law office

L70

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the words "ID SOLUTIONS" in navy blue color with the dot on the letter "I" of "ID" in turquoise blue color, located above the word "ONCOLOGY" in turquoise blue color. The group of words "ID SOLUTIONS ONCOLOGY" is located to the right of a turquoise blue and navy blue double helix.

Holders and representatives

Holders

ID SOLUTIONS ONCOLOGY

Representatives

J. Scott Gerien Dickenson, Peatman & Fogarty

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biochemical preparations, namely, precursors intended for in vitro genetic engineering; diagnostic reagents for in vitro use for biochemistry, clinical chemistry and microbiology; chemical preparations for scientific purposes intended for use in DNA analysis, other than for medical use; enzymes, other than for medical use, for continuous, homogeneous and isothermal amplification processes for DNA-specific models; chemical genetic identity tests comprised of reagents for nonmedical purposes; reagents for nucleic acid amplification other than for medical or veterinary use

Class 5

Diagnostic test kits comprised of medical diagnostic agents, preparations and substances for detecting gene mutations implicated in cancers; in vitro test kits for detecting genetic defects for medical purposes; chemical preparations intended for use in DNA analysis for medical use; reagents for use in medical genetic testing; genetic identity tests comprising reagents for medical use; preparations for detecting genetic predispositions for medical use; reagents for nucleic acid amplification for medical use

Class 9

Laboratory apparatus for detecting genetic sequences; quantitative polymerase chain reaction (PCR) instrument for scientific use, namely, thermal cycler; laboratory apparatus and automatic machines for purifying nucleic acids, not for medical purposes

Class 10

DNA and RNA testing apparatus for medical use; genetic testing apparatus for medical use; quantitative polymerase chain reaction (PCR) instrument for medical use, namely, thermal cycler; samplers for medical use, namely, sample preparation device for medical diagnostic use; medical apparatus and automatic machines for purifying nucleic acids for medical use

Class 42

Research with respect to DNA sequencing technology; research in the field of DNA analysis technology; scientific research in the field of genetics and genetic engineering; structural and functional analysis of genomes; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of health; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of biology; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of in vitro diagnostics; design, development and maintenance of software in the field of health; design, development and maintenance of software in the field of biology; design, development and maintenance of software in the field of in vitro diagnostics.

Publications

History of USPTO decisions and trademark events.

28 publications found

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

07/16/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/04/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/07/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/20/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/20/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/20/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/20/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

01/20/2026

GPNX

NOTIFICATION PROCESSED BY IB

12/11/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/02/2025

PUBO

PUBLISHED FOR OPPOSITION

12/02/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/26/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/26/2025

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/25/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/30/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/04/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/04/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/04/2025

RFNT

REFUSAL PROCESSED BY IB

06/07/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/22/2025

RFRR

REFUSAL PROCESSED BY MPU

05/22/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/27/2025

CNRT

NON-FINAL ACTION WRITTEN

03/26/2025

DOCK

ASSIGNED TO EXAMINER

03/06/2025

MAFR

APPLICATION FILING RECEIPT MAILED

12/05/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/05/2024

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

12/04/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/21/2024

Continuous trademark protection

Get notified about every new filing that threatens ID SOLUTIONS ONCOLOGY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.